For instance, IFNγ may contribute to cancer immune evasion by augmenting the expression of PD-L1 by tumor cells and dampening the anti-tumor activity of exhausted T-cells expressing PD-1 receptors [27,28]. This evidence concerns the gene CD274 and neoplasm.